Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States
- 16 December 2019
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 207, 107810
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoidsBrain Research Bulletin, 2016
- A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatmentClinical Toxicology, 2015
- Synthetic Cannabinoid–Related Illnesses and DeathsNew England Journal of Medicine, 2015
- Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implicationsDrug and Alcohol Dependence, 2014
- Behavioral Therapies for Treatment-Seeking Cannabis UsersEvaluation & the Health Professions, 2014
- CP47,497-C8 and JWH073, commonly found in ‘Spice’ herbal blends, are potent and efficacious CB1 cannabinoid receptor agonistsEuropean Journal of Pharmacology, 2011
- Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?Molecular Interventions, 2011
- JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB1receptor agonistBritish Journal of Pharmacology, 2010
- The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodesSchizophrenia Research, 2010
- Cannabis and psychosisThe Lancet, 2007